Molecular and functional characterization of common polymorphisms in HERG (KCNH2) potassium channels

Blake D Anson1, Michael J Ackerman, David J Tester

  • 1Department of Medicine, University of Wisconsin, 1300 University Ave., Madison, WI 53711, USA. bda@medicine.wisc.edu

Insights

Common genetic variations in the human ether-a-go-go-related gene (HERG) can alter cardiac channel function, potentially impacting heart rhythm and sudden death risk. This study identifies specific HERG polymorphisms with distinct electrophysiological properties.

Area of Science:

  • Cardiology
  • Genetics
  • Molecular Biology

Background:

  • Long QT syndrome (LQTS) is a disorder of cardiac repolarization linked to arrhythmias and sudden death.
  • Mutations in the human ether-a-go-go-related gene (HERG; KCNH2) cause LQT2, while drug-induced LQTS often involves HERG channel block.
  • Common genetic variants (polymorphisms) were traditionally considered benign, but recent findings suggest functional consequences.

Purpose of the Study:

  • To investigate whether common missense HERG polymorphisms alter channel physiology.
  • To identify and characterize the functional properties of common HERG polymorphisms.

Main Methods:

  • Comprehensive mutational analysis of HERG in population-based cohorts.
  • Heterologous expression of wild-type (WT) and polymorphic HERG channels in human embryonic kidney cells.
  • Biochemical and voltage-clamp techniques to assess channel processing and electrophysiological properties.

Main Results:

  • Four common HERG nonsynonymous single nucleotide polymorphisms (nSNPs) were identified: K897T, P967L, R1047L, and Q1068R.
  • K897T channels exhibited lower current density, altered activation potentials, and faster inactivation/recovery compared to WT.
  • Q1068R channels showed faster inactivation and recovery, while P967L and R1047L channels were electrophysiologically similar to WT.
  • All HERG variants displayed similar sensitivity to cisapride block.

Conclusions:

  • Some common HERG polymorphisms possess distinct electrophysiological properties that differ from wild-type channels.
  • These functional differences in HERG channels may contribute to cardiac repolarization abnormalities.
  • The study challenges the notion that common HERG polymorphisms are always functionally silent.

Related Concept Videos

Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Non-gated Ion Channels01:24

Non-gated Ion Channels

Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.
Non-gated Ion Channels01:24

Non-gated Ion Channels

Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...